Understanding STOM: Potential Drug Target and Biomarker (G2040)

Target Name: STOM

NCBI ID: G2040

STOM

Understanding STOM: Potential Drug Target and Biomarker

STOM (Protein 7.2b) is a protein that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and function have made it an attractive target for researchers to study and develop new treatments.

STOM is a transmembrane protein that is expressed in many different tissues throughout the body. It is made up of four subunits that are held together by disulfide bonds. The subunits are involved in various cellular processes, including signaling pathways, cell adhesion, and intracellular signaling.

One of the unique features of STOM is its ability to interact with other proteins. This interaction is known as STOM interaction and is a critical factor in the regulation of various cellular processes. STOM interactions have been observed with a wide range of proteins, including casein kinase 2 (CK-2), transforming growth factor beta (TGF-β), and the protein kinase B (PKB).

STOM has also been shown to play a role in the regulation of cell growth and differentiation. In addition, it has been linked to the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the most promising aspects of STOM is its potential as a drug target. The identification of STOM as a potential drug target makes it an attractive target for researchers to develop new treatments for a wide range of diseases.

In cancer, STOM has been shown to be involved in the regulation of cell growth, angiogenesis, and the development of resistance to chemotherapy. Therefore, STOM has been identified as a potential target for cancer therapies that target these processes.

In neurodegenerative diseases, STOM has been shown to be involved in the regulation of neurotransmitter synthesis and release, as well as the development and progression of neurodegeneration. Therefore, STOM has been identified as a potential target for neurodegenerative diseases therapies that target these processes.

In autoimmune disorders, STOM has been shown to be involved in the regulation of immune cell function and the development of autoimmune disease. Therefore, STOM has been identified as a potential target for autoimmune disorders therapies that target these processes.

In conclusion, STOM is a protein that has been identified as a potential drug target and biomarker for a wide range of diseases. Its unique structure and function have made it an attractive target for researchers to study and develop new treatments. Further research is needed to fully understand the role of STOM in disease and to develop effective therapies.

Protein Name: Stomatin

Functions: Regulates ion channel activity and transmembrane ion transport. Regulates ASIC2 and ASIC3 channel activity

The "STOM Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about STOM comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets